Who invested in Ascenta Therapeutics?
Ascenta Therapeutics's investors include Domain Associates, Sofinnova Investments, Enterprise Partners Venture Capital, U.S. Venture Partners and BA Venture Partners, and 1 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$88Mraised across 4 rounds since 2003, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $1.8M sold, first sale Jan 2010
From a historical funding record
From a historical funding record
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Ascenta Therapeutics's investors include Domain Associates, Sofinnova Investments, Enterprise Partners Venture Capital, U.S. Venture Partners and BA Venture Partners, and 1 more on record.
Ascenta Therapeutics has raised $88M across 4 rounds since 2003.
Ascenta Therapeutics's most recent round was a Debt of $1.8M in Feb 2010.
Ascenta Therapeutics's largest round on record is $50M (Series C), in Apr 2007.
Ascenta Therapeutics's first round on record, in Nov 2004, was backed by U.S. Venture Partners, Domain Associates and Sofinnova Investments and 2 others.
Ascenta Therapeutics's latest named round is a Debt, in Feb 2010.
Ascenta Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.